Health Care & Life Sciences » Medical Equipment & Supplies | BioElectronics Corp.

BioElectronics Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,445.60
2,677.30
2,450.20
2,106.70
2,118.80
2,988.30
Depreciation, Depletion & Amortization
16.60
16.70
11.00
3.20
2.20
2.20
Other Funds
-
-
51.70
77.10
11.40
1,094.10
Funds from Operations
1,894.40
1,913.20
1,532.70
1,351.40
1,310.20
1,892.10
Changes in Working Capital
295.20
101.00
187.00
43.80
441.30
539.70
Net Operating Cash Flow
1,599.20
2,014.20
1,719.70
1,307.60
868.90
1,352.40
Capital Expenditures
-
11.10
-
-
-
Net Investing Cash Flow
-
11.10
-
-
-
Issuance/Reduction of Debt, Net
1,606.80
2,042.00
1,870.50
1,246.10
883.40
Net Financing Cash Flow
1,606.80
2,042.00
1,818.80
1,169.00
872.00
Net Change in Cash
7.60
16.70
99.10
138.70
3.10
Free Cash Flow
1,599.20
2,025.30
1,719.70
1,307.60
868.90

About BioElectronics

View Profile
Address
4539 Metropolitan Court
Frederick Maryland 21704
United States
Employees -
Website http://www.bioelectronicscorp.com
Updated 07/08/2019
BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. Its products include ActiPatch, Allay, Smart Insole, HealFast, and RecoveryRx. The company was founded by Andrew J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.